非酒精性脂肪性肝病患者的肝外癌症风险高于肥胖
该纵向队列研究纳入1997-2016年美国人群中4,722例NAFLD患者及14,441例年龄性别匹配的对照,中位随访8年。NAFLD与恶性肿瘤风险升高90%相关(IRR=1.9, 95%CI 1.3-2.7),以肝癌、子宫癌、胃癌、胰腺癌和结肠癌风险增加为主;NAFLD相关癌症风险高于单纯肥胖。
要点
- NAFLD患者发生恶性肿瘤的风险较对照升高90%(IRR=1.9, 95%CI 1.3-2.7)。
- 风险增幅最高为肝癌(IRR=2.8),其次为子宫癌、胃癌、胰腺癌和结肠癌。
- 参照非肥胖对照,NAFLD与癌症风险升高相关(IRR=2.0),而单纯肥胖不相关(IRR=1.0)。
核心结论
- NAFLD与癌症风险增加相关,尤其是胃肠道肿瘤;在无NAFLD的情况下,肥胖与癌症风险的关联较小,提示NAFLD可能是肥胖-癌症关联的中介。
研究设计与样本
- 基于美国人群的纵向队列研究,1997-2016年识别所有NAFLD incident病例,按年龄和性别1:3匹配对照,NAFLD和癌症采用高有效性编码算法定义并经病历复核,使用Poisson回归分析关联。
- 共纳入4,722例NAFLD患者(中位年龄54岁,46%男性)和14,441例年龄性别匹配对照,中位随访8年(范围1-21年)。
主要发现
- 随访期间共发生2,224例incident癌症。
- NAFLD与恶性肿瘤风险升高90%相关:IRR=1.9(95%CI 1.3-2.7)。
- 风险增幅最高为肝癌IRR=2.8(95%CI 1.6-5.1),其次为子宫癌IRR=2.3(95%CI 1.4-4.1)、胃癌IRR=2.3(95%CI 1.3-4.1)、胰腺癌IRR=2.0(95%CI 1.2-3.3)和结肠癌IRR=1.8(95%CI 1.1-2.8)。
- 参照非肥胖对照,NAFLD与incident癌症风险升高相关(IRR=2.0, 95%CI 1.5-2.9),而单纯肥胖不相关(IRR=1.0, 95%CI 0.8-1.4)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Cancer is a major cause of death in patients with non-alcoholic fatty liver disease (NAFLD). Obesity is a risk factor for cancers; however, the role of NAFLD in this association is unknown. We investigated the effect of NAFLD versus obesity on incident cancers. METHODS: We identified all incident cases of NAFLD in a US population between 1997-2016. Individuals with NAFLD were matched by age and sex to referent individuals from the same population (1:3) on the index diagnosis date. We ascertained the incidence of cancer after index date until death, loss to follow-up or study end. NAFLD and cancer were defined using a code-based algorithm with high validity and tested by medical record review. The association between NAFLD or obesity and cancer risk was examined using Poisson regression. RESULTS: A total of 4,722 individuals with NAFLD (median age 54, 46% male) and 14,441 age- and sex-matched referent individuals were followed for a median of 8 (range 1-21) years, during which 2,224 incident cancers occurred. NAFLD was associated with 90% higher risk of malignancy: incidence rate ratio (IRR) = 1.9 (95% CI 1.3-2.7). The highest risk increase was noted in liver cancer, IRR = 2.8 (95% CI 1.6-5.1), followed by uterine IRR = 2.3 (95% CI 1.4-4.1), stomach IRR = 2.3 (95% CI 1.3-4.1), pancreas IRR = 2.0 (95% CI 1.2-3.3) and colon cancer IRR = 1.8 (95% CI 1.1-2.8). In reference to non-obese controls, NAFLD was associated with a higher risk of incident cancers (IRR = 2.0, 95% CI 1.5-2.9), while obesity alone was not (IRR = 1.0, 95% CI 0.8-1.4). CONCLUSIONS: NAFLD was associated with increased cancer risk, particularity of gastrointestinal types. In the absence of NAFLD, the association between obesity and cancer risk is small, suggesting that NAFLD may be a mediator of the obesity-cancer association. LAY SUMMARY: We studied the incidence of malignancies in a community cohort of adults with non-alcoholic fatty liver disease (NAFLD) in reference to age- and sex-matched adults without NAFLD. After 21 years of longitudinal follow-up, NAFLD was associated with a nearly 2-fold increase in the risk of developing cancers, predominantly of the liver, gastrointestinal tract and uterus. The association with increased cancer risk was stronger in NAFLD than obesity.
引用
- Allen AM, Hicks SB, Mara KC, et al. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. J Hepatol. 2019. PMID: 31470068. doi:10.1016/j.jhep.2019.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。